The Blood and Marrow Transplant and Cellular Immunotherapy (BMT CI) Program at Moffitt Cancer Center is the largest and most active program of its kind in the Southeast. Committed to providing every aspect of treatment and supportive care in a single, convenient location, Moffitt is an established leader in the field of bone marrow transplantation (BMT) and chimeric antigen receptor or CAR T cell therapy.
As a core member of the BMT Clinical Trials Network (BMT CTN), SWOG, and in collaboration with industry sponsors, Moffitt offers an advanced program that hosts a number of transplant and CAR T as well as other cutting-edge cellular immunotherapy clinical trials, offering patients the opportunity to benefit from specialized techniques and technologies that aren't yet available elsewhere.